Wei Su
Impact in
- Nephrology top 2%
- Chronic Kidney Disease and Diabetes
- Renal Diseases and Glomerulopathies
- Dialysis and Renal Disease Management
- Biological Psychiatry top 10%
Papers in
-
- Chronic Kidney Disease and Diabetes 6
- Renal Diseases and Glomerulopathies 3
-
- Ferroptosis and cancer prognosis 4
- Pulmonary Hypertension Research and Treatments 3
- Occupational and environmental lung diseases 3
- Co-authors
- Ying‐Yong Zhao (10 shared papers)Dan‐Qian Chen (6 shared papers)Nosratola D. Vaziri (6 shared papers)Xiao-Yong Yu (5 shared papers)Hua Chen (5 shared papers)Hua Miao (5 shared papers)Yanni Wang (4 shared papers)Gang Cao (4 shared papers)
- Journals
- British Journal of Pharmacology (3 papers)Clinica Chimica Acta (2 papers)Frontiers in Immunology (2 papers)Cell Proliferation (2 papers)Acta Pharmacologica Sinica (2 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Wei Su
68 papers receiving 1.7k citations
Wei Su's Hit Papers
Peers
Comparison fields: 5 of 122
- Nephrology 338
- Biological Psychiatry 44
- Pharmacology 90
- Clinical Biochemistry 62
- Health, Toxicology and Mutagenesis 118
Countries citing papers authored by Wei Su
This map shows the geographic impact of Wei Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Su more than expected).
Fields of papers citing papers by Wei Su
This network shows the impact of papers produced by Wei Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Su. The network helps show where Wei Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 234 | |
| 2 | 2017 | 150 | |
| 3 | 2017 | 112 | |
| 4 | Lactobacillus species ameliorate membranous nephropathy through inhibiting the aryl hydrocarbon receptor pathway via tryptophan‐produced indole metabolites Hit paper breakdown → | 2023 | 108 |
| 5 | Targeting Lactobacillus johnsonii to reverse chronic kidney disease Hit paper breakdown → | 2024 | 94 |
| 6 | 2020 | 69 | |
| 7 | 2002 | 64 | |
| 8 | 2021 | 56 | |
| 9 | 2019 | 53 | |
| 10 | 2018 | 47 | |
| 11 | 2019 | 47 | |
| 12 | 2023 | 46 | |
| 13 | 2007 | 41 | |
| 14 | 2020 | 41 | |
| 15 | 2023 | 40 | |
| 16 | 2004 | 34 | |
| 17 | 2017 | 34 | |
| 18 | 2005 | 31 | |
| 19 | 2016 | 27 | |
| 20 | 2020 | 27 |
About Wei Su
Wei Su is a scholar working on Nephrology, Pulmonary and Respiratory Medicine, Neurology, Pathology and Forensic Medicine and Oncology, having authored 73 papers that have together received 1.8k indexed citations. Recurring topics across this work include Chronic Kidney Disease and Diabetes (6 papers), Ferroptosis and cancer prognosis (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Reproductive Biology and Fertility (4 papers), Pulmonary Hypertension Research and Treatments (3 papers), Renal Diseases and Glomerulopathies (3 papers), Occupational and environmental lung diseases (3 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers). The work is most often cited by research in Nephrology (338 citations), Biological Psychiatry (44 citations), Pharmacology (90 citations), Clinical Biochemistry (62 citations) and Health, Toxicology and Mutagenesis (118 citations). Wei Su has collaborated with scholars based in China, United States and France. Frequent co-authors include Ying‐Yong Zhao, Dan‐Qian Chen, Nosratola D. Vaziri, Xiao-Yong Yu, Hua Chen, Hua Miao, Yanni Wang, Gang Cao, Yan Ping Guo and Shixing Ma. Their work appears in journals such as British Journal of Pharmacology, Clinica Chimica Acta, Frontiers in Immunology, Cell Proliferation and Acta Pharmacologica Sinica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.